Canada (CA)

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Gunshot Injuries to the Head (2024) Kasper EM, Algethami H, Takroni R, Kasper BS Authored book Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial (2024) Apperloo EM, Gorriz JL, Soler MJ, Cigarrán Guldris S, Cruzado JM, Puchades MJ, López-Martínez M, et al. Journal article Further delineation of the SCAF4-associated neurodevelopmental disorder (2024) Schmid CM, Gregor A, Ruiz A, Manso Bazús C, Herman I, Ammouri F, Kotzaeridou U, et al. Journal article What goes around comes around - work characteristics as both antecedents and outcomes of hybrid work adoption (2024) Handke L, O’Neill TA, McLarnon MJW, Kauffeld S Journal article Clinical Characteristics of Anti-synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project (2024) Faghihi-Kashani S, Yoshida A, Bozan F, Zanframundo G, Rozza D, Loganathan A, Dourado E, et al. Journal article SF-CORNER (splenic flexure colorectal cancer): an international survey of operative approaches and outcomes for cancers of the splenic flexure. (2024) Sekhar H, Dyer M, Khan M, Mitchell PJ, West NP, Moug S, Vimalachandran D Journal article Ferroptosis in health and disease. (2024) Berndt C, Alborzinia H, Amen VS, Ayton S, Barayeu U, Bartelt A, Bayir H, et al. Journal article, Review article Quantum enhanced electric field mapping within semiconductor devices (2024) Scheller D, Hrunski F, Schwarberg J, Knolle W, Soykal ÖO, Udvarhelyi P, Narang P, et al. Journal article, Letter Telemedicine networks for acute stroke: An analysis of global coverage, gaps, and opportunities (2024) Tunkl C, Agarwal A, Ramage E, Velez FS, Roushdy T, Ullberg T, Li L, et al. Journal article Correlation of changes in inflammatory and collagen biomarkers with durable guselkumab efficacy through 2 years in participants with active psoriatic arthritis: results from a phase III randomized controlled trial (2024) Siebert S, Schett G, Raychaudhuri SP, Guma M, Chen W, Gao S, Chakravarty SD, et al. Journal article